Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease characterized by the selective loss of upper and lower motor neurons. While the majority of ALS cases are sporadic, approximately 10% are familial, with mutations in the Cu/Zn superoxide dismutase 1 (SOD1) gene being among the first identified genetic causes. Although mutant SOD1 is primarily known for its role in oxidative stress through loss of normal function or gain of toxic properties, emerging evidence suggests that it also disrupts critical cellular processes such as mitochondrial dynamics and axonal transport—both essential for neuronal health and survival. This study investigates how different SOD1 mutations (G93A, G37R, H48Q) affect mitochondrial morphology, motility, and the integrity of axonal transport in a motor neuron-like cell model (NSC34). Using live-cell imaging, immunofluorescence staining, and quantitative analysis of mitochondrial parameters, we demonstrate that expression of mutant SOD1 leads to significant alterations in mitochondrial network structure, reduced mitochondrial motility, and impaired anterograde transport. Notably, the G93A mutation exhibits the most pronounced effects, resulting in fragmented mitochondria, decreased velocity and processivity of moving organelles, and increased pausing events. In contrast, the H48Q mutation shows milder disruptions, while the G37R mutation displays intermediate phenotypes. These findings suggest that distinct SOD1 mutations differentially impact mitochondrial dynamics and transport efficiency, which may contribute to the variable pathogenicity observed across ALS patients with different genotypes. Furthermore, our data indicate that these defects precede overt cell death, highlighting their potential role as early pathological markers in SOD1-linked ALS.
Introduction
Motor neurons are uniquely vulnerable to metabolic and structural stress due to their elongated axons and high energy demands. Maintaining mitochondrial homeostasis and efficient axonal transport is therefore crucial for neuronal function. Mitochondria are dynamic organelles that constantly undergo fission and fusion, allowing them to adapt to local energy needs and remove damaged components. Proper distribution of mitochondria along axons ensures adequate ATP supply at synaptic terminals and other distal sites. This process relies heavily on microtubule-based motor proteins such as kinesin and dynein, which transport mitochondria bidirectionally. In ALS, particularly in models involving mutant SOD1, multiple lines of evidence point toward early dysfunction in these systems. Previous studies have shown that mutant SOD1 aggregates can impair mitochondrial trafficking by interacting directly with motor complexes or disrupting cytoskeletal integrity. Moreover, altered mitochondrial dynamics—such as excessive fragmentation—are frequently observed in both patient-derived cells and animal models of ALS. However, whether specific SOD1 mutations differentially influence mitochondrial behavior remains unclear. Here, we utilize NSC34 motor neuron-like cells stably expressing wild-type human SOD1 (WTSOD1) or three disease-associated mutants: G93A, G37R, and H48Q. We perform time-lapse imaging to assess mitochondrial movement in living cells, quantify morphological changes using fluorescence microscopy, and analyze transport parameters including speed, directionality, pause frequency, and processivity. Our results reveal that each mutation induces unique perturbations in mitochondrial dynamics and axonal transport, with the G93A variant causing the most severe disruption. These findings underscore the importance of mutation-specific effects in determining disease progression and provide insight into potential mechanisms underlying neuronal vulnerability in SOD1-related ALS.
Methods
NSC34 cells were stably transfected with pIRESneo vectors containing either human WTSOD1, G93A, G37R, or H48Q SOD1 cDNA sequences. Transfected clones were selected using G418 (250 μg/ml) and maintained under standard culture conditions (DMEM with 10% FCS, 2 mM glutamine, 37°C, 5% CO₂). Cell viability was confirmed via trypan blue exclusion, and transgene expression was validated by RT-qPCR and Western blotting. For live-cell imaging, cells were seeded onto glass-bottom dishes and cultured overnight. Mitochondria were labeled using MitoTracker Deep Red FM (100 nM) for 30 minutes at 37°C, followed by washing and incubation in fresh medium. Time-lapse confocal microscopy was performed using a Zeiss LSM 880 system equipped with a heated stage (37°C) and a 63× oil objective. Z-stack images were acquired every 10 seconds over a period of 5 minutes, capturing mitochondrial movement within neurites. ImageJ software was used to track individual mitochondria manually or semi-automatically using the TrackMate plugin. Parameters analyzed included average velocity (μm/min), processivity (distance traveled before pausing), pause duration (seconds), and percentage of anterograde vs retrograde movements. Mitochondrial morphology was assessed by measuring the aspect ratio (length/width) and form factor (perimeter² / (4π × area)) from static images. A total of 15–20 cells per condition were imaged, with 3–5 neurites analyzed per cell. Statistical comparisons were made using one-way ANOVA with Tukey’s post-hoc test. Immunofluorescence staining for β-III tubulin (axon marker) and phosphorylated dynamin-related protein 1 (pDrp1 Ser616) was performed to evaluate cytoskeletal integrity and activation of fission machinery. Confocal images were captured using identical settings across all samples and quantified using ImageJ.
Results
Live-cell imaging revealed striking differences in mitochondrial dynamics among the various SOD1-expressing cell lines. In control (WTSOD1 and pIRES) cells, mitochondria exhibited robust, continuous movement along neurites with consistent velocities averaging 0.8–1.0 μm/min. Anterograde motion predominated, and pauses were brief and infrequent. In contrast, cells expressing the G93A mutant showed a marked reduction in overall mitochondrial motility. The average velocity dropped significantly to 0.4 μm/min (p < 0.001), and processivity declined sharply, indicating frequent interruptions during transit. Pauses were longer and more common, with some mitochondria remaining stationary for over 30 seconds.Toripalimab Protocol Additionally, the proportion of anterograde movement decreased, suggesting impaired kinesin-dependent transport.PMP22 Antibody In Vivo Mitochondria in G93A-expressing cells appeared highly fragmented, with a lower aspect ratio (mean 1.8 ± 0.2) and higher form factor (mean 1.6 ± 0.1), indicating increased fission and loss of tubular networks. The G37R mutant displayed intermediate phenotypes: moderate reduction in velocity (0.6 μm/min), mild fragmentation, and slightly increased pause frequency, but preserved directional bias. In H48Q-expressing cells, mitochondrial movement remained relatively intact, with only minor reductions in speed (0.7 μm/min) and no significant change in morphology or pause behavior compared to controls. Quantitative analysis confirmed that G93A mitochondria moved slower and paused more often than those in any other group (p < 0.01). Morphological analysis further supported this trend, showing that G93A cells had the highest percentage of small, punctate mitochondria (>60%), whereas H48Q cells retained a predominantly elongated network (>70%). Immunofluorescence staining revealed elevated levels of activated pDrp1 Ser616 in G93A and G37R cells, correlating with increased fission activity.PMID:34538551 In contrast, H48Q cells showed minimal pDrp1 accumulation, consistent with stable mitochondrial architecture. Axonal integrity, as assessed by β-III tubulin staining, was largely preserved across all groups, ruling out major cytoskeletal collapse as a primary cause of transport deficits. These results collectively indicate that the G93A mutation exerts the strongest negative influence on mitochondrial dynamics and transport, while H48Q has the least impact, with G37R falling between them.
Discussion
This study provides direct evidence that different SOD1 mutations exert distinct effects on mitochondrial dynamics and axonal transport in a motor neuron-like cellular model. The G93A mutation consistently induced the most severe phenotype, characterized by fragmented mitochondria, diminished motility, prolonged pauses, and reduced processivity. These changes likely stem from multiple factors: enhanced aggregation propensity, increased interaction with motor proteins like dynein, and activation of fission pathways via Drp1 phosphorylation. Indeed, our data show elevated pDrp1 levels specifically in G93A and G37R cells, implicating hyperactive fission as a key mechanism driving mitochondrial fragmentation. The G37R mutation, although less aggressive than G93A, still disrupted transport and promoted fission, possibly due to similar misfolding and aggregation patterns. In contrast, the H48Q mutation—being catalytically inactive and less prone to aggregation—exhibited minimal functional impairment, aligning with its relatively benign clinical profile in some patients. These findings highlight the importance of mutation-specific pathobiology in ALS. Importantly, the observed transport defects occurred without significant cell death or loss of axonal structure, suggesting they represent early subcellular events preceding neurodegeneration. This supports the hypothesis that mitochondrial mislocalization and energy deficit in distal axons may be initiating factors in motor neuron degeneration. The fact that G93A induces the most profound disruption correlates with its association with rapid disease onset and short survival in transgenic mouse models. Conversely, H48Q-linked ALS tends to have a slower progression, consistent with the milder cellular phenotype reported here. Our results also emphasize the need to consider mutation type when evaluating therapeutic strategies targeting mitochondrial health or axonal transport. Treatments effective for one mutation may not benefit others, underscoring the necessity of personalized approaches in ALS research. Future work will explore the molecular interactions between mutant SOD1 and motor complexes, as well as the role of oxidative stress and calcium dysregulation in exacerbating transport failure. Ultimately, understanding how specific mutations alter fundamental cellular processes like mitochondrial dynamics may lead to earlier diagnostic tools and targeted interventions for SOD1-linked ALS.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com